WSA has announced results for the third quarter of the financial year 2025/26 (April 1, 2026 – June 30, 2026) showing 3% organic revenue growth and an EBITDA margin improvement of 2%-points to 19.1%. The outlook for FY 2025/26 is confirmed and narrowed....
Continue reading at Audiology Worldnews
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a corporate financial update with no direct implications for clinical practice.
WS Audiology's continued revenue growth and improving margins reflect broader market resilience in the global hearing care industry, which can influence investment, pricing, and competitive dynamics for clinic owners and dispensers.
- 01WS Audiology posted 3% organic revenue growth in Q3 FY2025/26 (Apr–Jun 2026).
- 02EBITDA margin reached 19.1%, up 2 percentage points year-on-year.
- 03The company confirmed and narrowed its full-year financial outlook.
- 04Results indicate stable demand in the global hearing aid market.
WS Audiology achieved 3% organic revenue growth in Q3 FY2025/26.
press releasesupportedEBITDA margin improved by 2 percentage points to 19.1% in Q3 FY2025/26.
press releasesupported
